GEVO

14,910,334, the number of shares of Common Stock issued and outstanding as of February 10, 2017

Schnap Schnap 8,8%

http://secfilings.nasdaq.com/....&FormType=SC%2013G&View=html

“This extension gives Gevo and Whitebox additional time to amend and extend the terms and maturity of the remaining portion of Gevo’s senior debt. Whitebox has always been very supportive of Gevo, and we are confident that we will come up with a long-term solution that will enable us to execute on our business plan and ultimately get the company to profitability,” said Dr. Patrick Gruber, Gevo’s Chief Executive Officer.

 
1       This amount is unaudited and preliminary, and does not present all information necessary for an understanding of our financial condition as of December 31, 2016. The review of our financial statements for the year ended December 31, 2016 is ongoing and could result in changes to this amount.

http://secfilings.nasdaq.com/...20INC.&FormType=8-K&View=html

0,57 Mio H-Units zu 1,89$ = 1,0773 Mio$ Kaufpreis bestehen aus                                                  1 L- Pre-Fund-Warrant (1,89$ gezahlt mit dem Kaufpreis)  Ausübbar bis 17.Feb.2018                       1 K-Warrant mit einem Ausübungspreis von 2,35$ . Ausübbar bis 17.Feb.2022                                 1 M-Warrant mit einem Ausübungspreis von 2,35$. Ausübbar bis 17.Nov 2017  

The gross proceeds to the Company from the Offering are expected to be approximately $11.9 million, not including any future proceeds from the exercise of the Warrants.

WENN alle Warrants zu dem Ausübungspreis ausgeübt werden, kann sich GEVO über zusätzliche 29,38 Mio$ freuen.                                                                                                               

Und die Aktionäre auf 18,75 Mio zusätzliche Aktien auf die 14,910,334 Shares Out (stand10.2.17)

Hier wäre mal dringend eine Untersuchung durch die SEC, FBI, CIA notwendig, wie es auch laut in den US-Foren gefordert wird.

Auszug aus : http://seekingalpha.com/article/4045943-gevo-hot-mess

Am 13. Februar 2017 kündigte Gevo ein öffentliches Angebot von Aktien und Optionsscheinen an, mit dem Ziel, 15% des Erlöses aus diesem Verkauf zu verwenden, um vorrangig gesicherte Schuldverschreibungen zu zahlen, die in diesem Jahr fällig sind. Das Unternehmen hat rund 36 Millionen Dollar in langfristige Schulden und 29 Millionen Dollar Umsatz.  Gevo verbrennt ca. $ 28 Million Bargeld durch den Betrieb jedes Jahr. Aber was am meisten beunruhigt ist seine abgrundtiefe Brutto-Marge von -32% - dies entspricht einem Bruttogewinn (Verlust) von $ 9 Millionen pro Jahr.

In diesem Sinne sollte es nicht überraschen, dass Gevo gezwungen war, sich an die Aktienmärkte für dringend benötigte Bargeld zu wenden.

Seit September sind die Anleger im Vorgriff auf diese scheinbar unvermeidliche Kapitalerhöhung geflohen. Die Marktkapitalisierung von Gevo sank von 65 Millionen Dollar auf nur 25 Millionen Dollar in der zweiten Hälfte des Jahres 2016, doch sobald 2017 begonnen hatte, sprangen "short interest " durch die Decke und setzten die Marktkapitalisierung auf nur 12,55 Millionen Dollar.

Wo geht die Reise wohl hin?!!!!!!!

 ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES . The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

(a) Adjustment Upon Issuance of Common Stock . If and whenever on or after the Subscription Date, the Company issues or sells, or in accordance with this Section 2 is deemed to have issued or sold, any shares of Common Stock (including the issuance or sale of shares of Common Stock owned or held by or for the account of the Company, but excluding shares of Common Stock deemed to have been issued or sold by the Company in connection with any Excluded Securities) for a consideration per share (the “ New Issuance Price ”) less than a price (the “ Applicable Price ”) equal to the Exercise Price in effect immediately prior to such issuance or sale or deemed issuance or sale (the foregoing a “ Dilutive Issuance ”), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price; provided, however, that in no event shall the Exercise Price be less than $0.10 per share (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events). For purposes of determining the adjusted Exercise Price under this Section 2(a), the following shall be applicable:

(i) Issuance of Options . If the Company in any manner grants or sells any Options and the lowest price per share for which one share of Common Stock is issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Options is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Options for such price per share. For purposes of this Section 2(a)(i), the “lowest price per share for which one share of Common Stock is issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Options” shall be equal to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the granting or sale of the Options, upon exercise of the Options and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Options less any consideration paid or payable by the Company with respect to such one share of Common Stock upon the granting or sale of such Options, upon exercise of such Options and upon conversion exercise or exchange of any Convertible Security issuable upon exercise of such Options. No further adjustment of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock or of such Convertible Securities upon the exercise of such Options or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.

(ii) Issuance of Convertible Securities . If the Company in any manner issues or sells any Convertible Securities and the lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 2(a)(ii), the “lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof” shall be equal to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security less any consideration paid or payable by the Company with respect to such one share of Common Stock upon the issuance or sale of such Convertible Security and upon conversion, exercise or exchange of such Convertible Security. No further adjustment of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of the Exercise Price has been or is to be made pursuant to other provisions of this Section 2(a), no further adjustment of the Exercise Price shall be made by reason of such issuance or sale.

(iii) Change in Option Price or Rate of Conversion. If the purchase price provided for in any Options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time, the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price, which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 2(a)(iii), if the terms of any Option or Convertible Security that was outstanding as of the Subscription Date are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 2(a) shall be made if such adjustment would result in an increase of the Exercise Price then in effect.

(iv) Calculation of Consideration Received . In case any Option is issued in connection with the issuance or sale of other securities of the Company, together comprising one integrated transaction, (x) the Options will be deemed to have been issued for the Option Value of such Options and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms of such other securities of the Company, less (II) the Option Value of such Options; provided, that if the value determined pursuant to clause (y) above would result in a value less than the par value of the Common Stock, then the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the par value of the Common Stock. If any shares of Common Stock, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company will be the Closing Sale Price of such publicly traded securities on the date of receipt of such publicly traded securities. If any shares of Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock, Options or Convertible Securities, as the case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the Company and the Required Holders. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “ Valuation Event ”), the fair value of such consideration will be determined within five (5) Business Days after the tenth (10 th ) day following the Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.

(v) Record Date . If the Company takes a record of the holders of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.

(vi) No Readjustments . For the avoidance of doubt, in the event the Exercise Price has been adjusted pursuant to this Section 2(a) and the Dilutive Issuance that triggered such adjustment is unwound or is cancelled after the facts for any reason whatsoever, in no event shall the Exercise Price be readjusted to the Exercise Price that would have been in effect if such Dilutive Issuance had not occurred or been consummated.

(b) Voluntary Adjustment By Company . The Company may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors of the Company.

(c) Adjustment Upon Subdivision or Combination of Common Stock . If the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Subscription Date combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 2(c) shall become effective at the close of business on the date the subdivision or combination becomes effective.

(d) Other Events . If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the Company’s Board of Directors will make an appropriate adjustment in the Exercise Price and the number of Warrant Shares, as mutually determined by the Company’s Board of Directors and the Required Holders, so as to protect the rights of the Holder; provided that no such adjustment pursuant to this Section 2(d) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 2.

http://secfilings.nasdaq.com/...20INC.&FormType=8-K&View=html

man hört und liest ja nichts mehr von GEVO dazu....

...obgleich mir die Lufthansa im Dezember noch geantwortet hatte wie folgt:

vielen Dank für Ihr Schreiben vom 26. Dezember.

Sie haben völlig recht – der GEVO Vertrag wurde mit einer Firma aus den USA abgeschlossen. Wir hatten fälschlicherweise an NExBTL gedacht und die Informationen verwechselt (ebenfalls ein Biokraftstoff Projekt). Im September hat Lufthansa einen Vertrag unterzeichnet in dem feststeht, dass Lufthansa 8 Miliionen Liter Biokraftstoff pro Jahr vom Hersteller kauft um diesen mit normalem Kerosin zu vermischen.

Wir danken Ihnen für Ihre Unterstützung.customer.relations@lufthansa.com

Eine Schande, dass so eine Idee / Produkt, so ein schlechtes Management hat. Das sind alles nur Bauern und keine Kaufleute / Finanzexperten